Indivior PLC Ordinary Shares (INDV) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $34.88 (-2.27%), Market cap $4.47B, P/E ratio 19.40, 52-week low–high $11.21 ~ $40.61.
Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD)
Financial statements, price targets, institutional (13F) holdings and related news for Indivior PLC Ordinary Shares are updated in real time on BlackAll Trade.
Indivior PLC Ordinary Shares trades at $34.88 (-2.27%). Real-time quotes and charts are available on BlackAll Trade.
Indivior PLC Ordinary Shares has a market cap of about $4.47B. Its P/E ratio is 19.40.
Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and r